Cargando…
A novel functional polymorphism of GSTM3 reduces clear cell renal cell carcinoma risk through enhancing its expression by interfering miR‐556 binding
Dysregulation of glutathione‐S‐transferase M3 (GSTM3) has been related to clear cell renal cell carcinoma (ccRCC) in our former study. GSTM3 plays a pivotal role of detoxification and clearance of reactive oxygen species (ROS) in tumour tissues. This study aimed to examine: (1) the associations betw...
Autores principales: | Wang, Ying, Yang, Zi‐Ying, Chen, Yi‐Huan, Li, Feng, Shen, Han, Yu, You, Huang, Hao‐Yue, Shen, Zhen‐Ya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980204/ https://www.ncbi.nlm.nih.gov/pubmed/29569387 http://dx.doi.org/10.1111/jcmm.13528 |
Ejemplares similares
-
GSTM3 Function and Polymorphism in Cancer: Emerging but Promising
por: Wang, Shunda, et al.
Publicado: (2020) -
GSTM1 copy number variation in the context of single nucleotide polymorphisms in the human GSTM cluster
por: Khrunin, Andrey V., et al.
Publicado: (2016) -
Circ‐LAMP1 contributes to the growth and metastasis of cholangiocarcinoma via miR‐556‐5p and miR‐567 mediated YY1 activation
por: Xu, Yi, et al.
Publicado: (2021) -
Frequencies of glutathione s-transferase (GSTM1, GSTM3 AND GSTT1) polymorphisms in a Malaysian population
por: Alshagga, Mustafa A., et al.
Publicado: (2011) -
Complex evolution of the GSTM gene family involves sharing of GSTM1 deletion polymorphism in humans and chimpanzees
por: Saitou, M., et al.
Publicado: (2018)